Capital Flow Monitor · Sponsors · CIK 2095500
Bio Usawa Inc.
100 PINE STREET, SAN FRANCISCO, CA, 94111 · 2405054396
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$1.7M
Sold
$1.7M
% sold
100.0%
Investors
25
Min investment
$5K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-27 | D/A | 506(b) | — | $500K | — | 7 | EDGAR ↗ |
| 2025-12-17 | D | 506(b) | $450K | $450K | 100.0% | 6 | EDGAR ↗ |
| 2025-12-17 | D ·current | 506(b) | $1.7M | $1.7M | 100.0% | 25 | EDGAR ↗ |
| 2025-12-17 | D | 506(b) | $404K | $404K | 100.0% | 5 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Menghis Bairu — Executive Officer / Director, San Mateo, CA
-
Richard Chin — Director, San Francisco, CA
1 other raise
- Vetmab Biosciences, Inc. $11.4M of $11.9M · 95.8%
- John Hautman — Executive Officer, Harrison, OH
- Vincent Ancinetti — Director, San Mateo, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.